| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |